01 1Cadila Pharmaceuticals
01 1ATORVASTATIN CALCIUM USP FORM-I
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-07
Pay. Date : 2014-04-17
DMF Number : 28122
Submission : 2014-04-16
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATORVASTATIN CALCIUM USP FORM-I, with a corresponding US DMF Number 28122.
Remarkably, this DMF maintains an Active status since its submission on April 16, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2014, and payment made on April 17, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
